Leena Kumari Prasad is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as stimulators of soluble guanylate cyclase (sGC). With a total of two patents to her name, her work is recognized for its potential impact on the treatment of various disorders.

Latest Patents

Leena's latest patents focus on crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine. These compounds are useful as sGC stimulators. The disclosures provide not only the crystalline forms but also pharmaceutically acceptable compositions that include these forms. Furthermore, the methods of using these compositions in treating various disorders are also outlined in her patents.

Career Highlights

Throughout her career, Leena has worked with prominent companies in the pharmaceutical industry. She has been associated with Cyclerion Therapeutics, Inc. and Tisento Therapeutics Inc. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Leena has collaborated with several professionals in her field, including Kwame Wiredu Nti-Addae and Thomas Storz. These collaborations have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Leena Kumari Prasad is a distinguished inventor whose work in pharmaceutical chemistry has the potential to advance medical treatments. Her innovative contributions and collaborations reflect her commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.